CTOs on the Move

intellyst Medical Communications

www.intellyst.com

 
intellyst Medical Communications is a Aurora, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.intellyst.com
  • 2101 S Blackhawk St Ste 240
    Aurora, CO USA 80014
  • Phone: 703.729.8964

Executives

Name Title Contact Details

Similar Companies

SwedishAmerican Health System

SwedishAmerican Health System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. SwedishAmerican Health System is based in Rockford, IL. You can find more information on SwedishAmerican Health System at www.swedishamerican.org

Community Health Action of Staten Island

In 1988, a group of advocates, providers, and consumers created the Staten Island AIDS Task Force in response to the health crisis of HIV and AIDS in our community. For many years, the Task Force was the only non-profit community-based organization who...

DSG

DSG develops software and service solutions for the clinical trial industry.

Sacred Heart Health System

Sacred Heart Health System, Inc., doing business as Sacred Heart Hospital, provides health care services to children and adults in Northwest Florida. It operates children's and women's hospitals; heart and vascular, and neurology and neurosurgery institutes; emergency/trauma, stroke, cancer, women's services, joint replacement surgery, and weight loss surgery centers; and a network of physicians. The company was founded in 1915 and is based in Pensacola, Florida with hospitals in South Walton County and Gulf County. Sacred Heart Health System, Inc. operates as a subsidiary of Ascension Health.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.